Просмотр новости
Найдите то, что Вас интересует
Спутники
РН
SpaceX
Роскосмос
NASA
СпутникиРНSpaceXРоскосмосNASANEW YORK (AP) — Popular — and expensive — GLP-1 weight loss drugs just got a lot cheaper for many older Americans. Starting Wednesday, the federal government is offering a selection of the brand name medications to certain Medicare and Medicare Advantage beneficiaries for $50 a month through a new trial called Medicare GLP-1 Bridge. [...]
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Medicare is now covering some GLP-1 weight loss drugs for $50. Here’s what to know | 5 | 7 | 01-07-2026 |
| 2 | Medicare now covering some GLP-1s for $50. Here's what to know | 5 | 7 | 02-07-2026 |
| 3 | Medicare now covering some GLP-1s for $50. Here's what to know | 5 | 7 | 02-07-2026 |
| 4 | Medicare is now covering some GLP-1 weight loss drugs for $50. Here’s what to know | 5 | 5 | 01-07-2026 |
| 5 | GLP-1 use hits record high as Medicare opens access to weight-loss drugs | 0 | 7 | 09-07-2026 |
| 6 | Women more often hired after losing weight on GLP-1s: Study | 0.2 | 0.6 | 03-07-2026 |
| 7 | Women more often hired after losing weight on GLP-1s: Study | 0 | 5 | 03-07-2026 |
| 8 | Novo Nordisk’s obesity drug Wegovy gets CDSCO approval to treat liver condition | 5 | 7 | 17-07-2026 |
| 9 | GLP-1 drugs could reduce long-term sick leave: Study | 0 | 18.9 | 26-07-2026 |
| 10 | GLP-1 drugs could reduce long-term sick leave: Study | 0 | 18.9 | 26-07-2026 |